A2 Milk sinks 11% as FDA defers new approvals

A2 Milk sinks 11% as FDA defers new approvals
Market disappointed with A2 news. (Image: Getty)
Rebecca Howard
A2 Milk sank 11% on news it won’t be sending infant formula to the lucrative US market any time soon.According to the company, the US Food and Drug Administration (FDA) is deferring further consideration of the company’s request for enforcement discretion to import infant milk formula products into the US.Last week, the company's shares jumped on an Australian news report that approval might be imminent. While A2 Milk moved quickly to dampen those expectations, the shares remained elevated, peaking at $5.64 on Friday.They recent...

More Primary Sector

Bell Potter boosts Santana target price 53.5%
Primary Sector

Bell Potter boosts Santana target price 53.5%

Aussie brokers increasingly like the look of a low-cost, high yield Otago gold play.

Pattrick Smellie 19 Apr 2024
Anna Palairet appointed Fonterra's chief operating officer
Primary Sector

Anna Palairet appointed Fonterra's chief operating officer

Having acted in the role since June last year, she replaces Fraser Whineray.

Riley Kennedy 19 Apr 2024
Progress takes more than Groundhog Day rhetoric
Primary Sector

Julia Jones: Progress takes more than Groundhog Day rhetoric

There seems to be a noticeable lack of innovation in NZ's red meat export industry.

Julia Jones 19 Apr 2024
Tough season for Terra Vitae Vineyards
Primary Sector

Tough season for Terra Vitae Vineyards

The yield from this year's harvest was 20% below the budgeted amount.

Rebecca Howard 19 Apr 2024